Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China
· Delayed Price · Currency is CNY 31.96
-0.41 (-1.27%)
Mar 11, 2026, 3:04 PM CST
SHE:301130 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 251.61 | 255.25 | 225.14 | 255.4 | 285.14 | 284.79 | Upgrade
|
| Other Revenue | 1.16 | 1.16 | 0.35 | 0.07 | 0.51 | 1.53 | Upgrade
|
| Revenue | 252.77 | 256.41 | 225.49 | 255.47 | 285.66 | 286.32 | Upgrade
|
| Revenue Growth (YoY) | 2.10% | 13.71% | -11.73% | -10.57% | -0.23% | -11.88% | Upgrade
|
| Cost of Revenue | 60.01 | 61.16 | 45.52 | 47.42 | 46.98 | 44.32 | Upgrade
|
| Gross Profit | 192.76 | 195.24 | 179.97 | 208.05 | 238.68 | 242 | Upgrade
|
| Selling, General & Admin | 143.28 | 144.9 | 142.24 | 153.66 | 168.88 | 180.9 | Upgrade
|
| Research & Development | 8.18 | 10.22 | 8.7 | 11.74 | 13.31 | 4.37 | Upgrade
|
| Other Operating Expenses | 7.59 | 4.97 | 5.88 | 6.42 | 7.92 | 8.36 | Upgrade
|
| Operating Expenses | 159.27 | 160.74 | 156.29 | 171.77 | 190.43 | 193.54 | Upgrade
|
| Operating Income | 33.49 | 34.5 | 23.69 | 36.28 | 48.25 | 48.46 | Upgrade
|
| Interest Expense | -0.38 | -0.07 | -0.05 | - | - | - | Upgrade
|
| Interest & Investment Income | 4.73 | 6.82 | 13.35 | 11.36 | 3.85 | 3.89 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.65 | -0.06 | -0.05 | -0.01 | -0.04 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | 38.5 | 41.2 | 36.93 | 47.63 | 52.05 | 52.39 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.17 | 0.74 | 3.15 | 1.17 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.5 | -0.5 | 1.87 | - | - | -0.02 | Upgrade
|
| Asset Writedown | 0.4 | -0 | -0.17 | -0 | -0.17 | -0 | Upgrade
|
| Other Unusual Items | 5.14 | 5.08 | 16.53 | 1.64 | 7.32 | 6.56 | Upgrade
|
| Pretax Income | 43.71 | 46.51 | 58.31 | 50.43 | 59.21 | 58.93 | Upgrade
|
| Income Tax Expense | 6.16 | 6.25 | 7.81 | 9.71 | 7.19 | 9.18 | Upgrade
|
| Net Income | 39.35 | 40.27 | 50.5 | 40.72 | 52.02 | 49.74 | Upgrade
|
| Net Income to Common | 39.35 | 40.27 | 50.5 | 40.72 | 52.02 | 49.74 | Upgrade
|
| Net Income Growth | -9.07% | -20.26% | 24.01% | -21.71% | 4.58% | -8.92% | Upgrade
|
| Shares Outstanding (Basic) | 76 | 78 | 81 | 77 | 61 | 61 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 78 | 81 | 77 | 61 | 61 | Upgrade
|
| Shares Change (YoY) | -3.07% | -3.66% | 4.35% | 27.78% | -0.00% | 0.00% | Upgrade
|
| EPS (Basic) | 0.51 | 0.52 | 0.63 | 0.53 | 0.86 | 0.82 | Upgrade
|
| EPS (Diluted) | 0.51 | 0.52 | 0.63 | 0.53 | 0.86 | 0.82 | Upgrade
|
| EPS Growth | -6.19% | -17.23% | 18.84% | -38.73% | 4.58% | -8.92% | Upgrade
|
| Free Cash Flow | -15.79 | -80.73 | -68.79 | 12.83 | 37.83 | 50.03 | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -1.04 | -0.85 | 0.17 | 0.62 | 0.83 | Upgrade
|
| Dividend Per Share | 0.260 | 0.260 | 0.260 | 0.160 | 0.130 | - | Upgrade
|
| Dividend Growth | - | - | 62.50% | 23.08% | - | - | Upgrade
|
| Gross Margin | 76.26% | 76.15% | 79.81% | 81.44% | 83.55% | 84.52% | Upgrade
|
| Operating Margin | 13.25% | 13.46% | 10.50% | 14.20% | 16.89% | 16.93% | Upgrade
|
| Profit Margin | 15.57% | 15.71% | 22.40% | 15.94% | 18.21% | 17.37% | Upgrade
|
| Free Cash Flow Margin | -6.25% | -31.49% | -30.51% | 5.02% | 13.24% | 17.47% | Upgrade
|
| EBITDA | 58.81 | 56.92 | 42.23 | 54.77 | 66.96 | 68.92 | Upgrade
|
| EBITDA Margin | 23.27% | 22.20% | 18.73% | 21.44% | 23.44% | 24.07% | Upgrade
|
| D&A For EBITDA | 25.32 | 22.42 | 18.55 | 18.49 | 18.71 | 20.46 | Upgrade
|
| EBIT | 33.49 | 34.5 | 23.69 | 36.28 | 48.25 | 48.46 | Upgrade
|
| EBIT Margin | 13.25% | 13.46% | 10.50% | 14.20% | 16.89% | 16.93% | Upgrade
|
| Effective Tax Rate | 14.08% | 13.43% | 13.39% | 19.25% | 12.14% | 15.59% | Upgrade
|
| Revenue as Reported | 252.77 | 256.41 | 225.49 | 255.47 | 285.66 | 286.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.